

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | axon ensheathment in central nervous system (GO:0032291) | 9.57422978 |
| 2 | central nervous system myelination (GO:0022010) | 9.57422978 |
| 3 | fatty acid elongation (GO:0030497) | 8.16463023 |
| 4 | ensheathment of neurons (GO:0007272) | 6.15102083 |
| 5 | axon ensheathment (GO:0008366) | 6.15102083 |
| 6 | myelination (GO:0042552) | 6.12936073 |
| 7 | protoporphyrinogen IX metabolic process (GO:0046501) | 5.92009922 |
| 8 | protoporphyrinogen IX biosynthetic process (GO:0006782) | 5.80527276 |
| 9 | cholesterol biosynthetic process (GO:0006695) | 5.77852825 |
| 10 | sterol biosynthetic process (GO:0016126) | 5.03359320 |
| 11 | long-chain fatty acid biosynthetic process (GO:0042759) | 4.89647121 |
| 12 | glycerophospholipid catabolic process (GO:0046475) | 4.89549806 |
| 13 | myelin maintenance (GO:0043217) | 4.57231695 |
| 14 | response to methylmercury (GO:0051597) | 4.53562269 |
| 15 | isoprenoid biosynthetic process (GO:0008299) | 4.50790312 |
| 16 | establishment of mitochondrion localization (GO:0051654) | 4.34956579 |
| 17 | creatine metabolic process (GO:0006600) | 4.22461143 |
| 18 | ribosomal small subunit assembly (GO:0000028) | 4.19515114 |
| 19 | heme transport (GO:0015886) | 4.15767373 |
| 20 | * heme biosynthetic process (GO:0006783) | 4.14860746 |
| 21 | long-chain fatty-acyl-CoA biosynthetic process (GO:0035338) | 4.13491466 |
| 22 | negative regulation of neurotransmitter secretion (GO:0046929) | 4.07560298 |
| 23 | ribosomal large subunit biogenesis (GO:0042273) | 4.04922274 |
| 24 | L-methionine biosynthetic process from methylthioadenosine (GO:0019509) | 4.02082927 |
| 25 | peptidyl-cysteine modification (GO:0018198) | 3.89557393 |
| 26 | L-phenylalanine catabolic process (GO:0006559) | 3.87823928 |
| 27 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 3.87823928 |
| 28 | fatty-acyl-CoA biosynthetic process (GO:0046949) | 3.87249789 |
| 29 | * porphyrin-containing compound biosynthetic process (GO:0006779) | 3.81185010 |
| 30 | pyrimidine deoxyribonucleotide catabolic process (GO:0009223) | 3.76525575 |
| 31 | * heme metabolic process (GO:0042168) | 3.74829758 |
| 32 | adhesion of symbiont to host cell (GO:0044650) | 3.74091995 |
| 33 | virion attachment to host cell (GO:0019062) | 3.74091995 |
| 34 | activation of cysteine-type endopeptidase activity involved in apoptotic process by cytochrome c (GO | 3.72119038 |
| 35 | GPI anchor biosynthetic process (GO:0006506) | 3.70446187 |
| 36 | amino acid salvage (GO:0043102) | 3.68787954 |
| 37 | L-methionine salvage (GO:0071267) | 3.68787954 |
| 38 | L-methionine biosynthetic process (GO:0071265) | 3.68787954 |
| 39 | response to lead ion (GO:0010288) | 3.68233258 |
| 40 | amyloid precursor protein metabolic process (GO:0042982) | 3.65686054 |
| 41 | long-chain fatty-acyl-CoA metabolic process (GO:0035336) | 3.65404719 |
| 42 | formation of translation preinitiation complex (GO:0001731) | 3.63245338 |
| 43 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 3.61726072 |
| 44 | L-phenylalanine metabolic process (GO:0006558) | 3.61726072 |
| 45 | proteasome assembly (GO:0043248) | 3.61227937 |
| 46 | rRNA modification (GO:0000154) | 3.58351868 |
| 47 | substantia nigra development (GO:0021762) | 3.55599638 |
| 48 | L-serine metabolic process (GO:0006563) | 3.55435607 |
| 49 | ribonucleoprotein complex biogenesis (GO:0022613) | 3.55373856 |
| 50 | ribosome biogenesis (GO:0042254) | 3.55246438 |
| 51 | fatty-acyl-CoA metabolic process (GO:0035337) | 3.54063576 |
| 52 | oligodendrocyte differentiation (GO:0048709) | 3.53173047 |
| 53 | preassembly of GPI anchor in ER membrane (GO:0016254) | 3.49388384 |
| 54 | GPI anchor metabolic process (GO:0006505) | 3.46874499 |
| 55 | positive regulation of cellular amine metabolic process (GO:0033240) | 3.44368053 |
| 56 | establishment of integrated proviral latency (GO:0075713) | 3.43564947 |
| 57 | * tetrapyrrole biosynthetic process (GO:0033014) | 3.41783526 |
| 58 | regulation of collateral sprouting (GO:0048670) | 3.40218334 |
| 59 | * porphyrin-containing compound metabolic process (GO:0006778) | 3.39283108 |
| 60 | iron coordination entity transport (GO:1901678) | 3.38166174 |
| 61 | negative regulation of neurotransmitter transport (GO:0051589) | 3.36193236 |
| 62 | very long-chain fatty acid metabolic process (GO:0000038) | 3.36123307 |
| 63 | ribosomal small subunit biogenesis (GO:0042274) | 3.35735837 |
| 64 | regulation of mitochondrial translation (GO:0070129) | 3.35079929 |
| 65 | mitochondrial electron transport, NADH to ubiquinone (GO:0006120) | 3.33556658 |
| 66 | apical protein localization (GO:0045176) | 3.32008910 |
| 67 | ribosome assembly (GO:0042255) | 3.30925457 |
| 68 | acyl-CoA biosynthetic process (GO:0071616) | 3.30644275 |
| 69 | thioester biosynthetic process (GO:0035384) | 3.30644275 |
| 70 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 3.29530309 |
| 71 | maturation of SSU-rRNA (GO:0030490) | 3.28822918 |
| 72 | DNA ligation (GO:0006266) | 3.27630653 |
| 73 | DNA strand elongation involved in DNA replication (GO:0006271) | 3.26166037 |
| 74 | pyrimidine nucleotide catabolic process (GO:0006244) | 3.25829859 |
| 75 | nuclear envelope reassembly (GO:0031468) | 3.25208672 |
| 76 | mitotic nuclear envelope reassembly (GO:0007084) | 3.25208672 |
| 77 | viral transcription (GO:0019083) | 3.22092465 |
| 78 | asymmetric protein localization (GO:0008105) | 3.22005825 |
| 79 | negative regulation of tumor necrosis factor-mediated signaling pathway (GO:0010804) | 3.20580947 |
| 80 | membrane tubulation (GO:0097320) | 3.18882787 |
| 81 | response to redox state (GO:0051775) | 3.18222127 |
| 82 | chaperone-mediated protein transport (GO:0072321) | 3.18160928 |
| 83 | DNA strand elongation (GO:0022616) | 3.17203233 |
| 84 | protein neddylation (GO:0045116) | 3.16782572 |
| 85 | negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051436) | 3.15306159 |
| 86 | deoxyribonucleoside monophosphate metabolic process (GO:0009162) | 3.14300770 |
| 87 | astrocyte development (GO:0014002) | 3.12876650 |
| 88 | telomere maintenance via semi-conservative replication (GO:0032201) | 3.12280869 |
| 89 | translational termination (GO:0006415) | 3.09444376 |
| 90 | translational elongation (GO:0006414) | 3.05312734 |
| 91 | pseudouridine synthesis (GO:0001522) | 3.04019923 |
| 92 | serine family amino acid biosynthetic process (GO:0009070) | 3.03229658 |
| 93 | axon development (GO:0061564) | 3.02905356 |
| 94 | histone H2B ubiquitination (GO:0033523) | 3.02692357 |
| 95 | termination of RNA polymerase III transcription (GO:0006386) | 3.01960890 |
| 96 | transcription elongation from RNA polymerase III promoter (GO:0006385) | 3.01960890 |
| 97 | SRP-dependent cotranslational protein targeting to membrane (GO:0006614) | 3.00086339 |
| 98 | import into cell (GO:0098657) | 2.98827042 |
| 99 | establishment of viral latency (GO:0019043) | 2.98689869 |
| 100 | ribonucleoprotein complex disassembly (GO:0032988) | 2.97933734 |
| 101 | negative regulation of peptidyl-threonine phosphorylation (GO:0010801) | 2.95980143 |
| 102 | regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051439) | 2.95640816 |
| 103 | microtubule polymerization or depolymerization (GO:0031109) | 2.94571479 |
| 104 | glutathione biosynthetic process (GO:0006750) | 2.94356120 |
| 105 | transcription from mitochondrial promoter (GO:0006390) | 2.94238962 |
| 106 | respiratory electron transport chain (GO:0022904) | 2.94191135 |
| 107 | protein palmitoylation (GO:0018345) | 2.92995927 |
| 108 | base-excision repair (GO:0006284) | 2.92915171 |
| 109 | nucleotide transmembrane transport (GO:1901679) | 2.92722964 |
| 110 | ATP synthesis coupled proton transport (GO:0015986) | 2.91382151 |
| 111 | energy coupled proton transport, down electrochemical gradient (GO:0015985) | 2.91382151 |
| 112 | translational initiation (GO:0006413) | 2.90736109 |
| 113 | adhesion of symbiont to host (GO:0044406) | 2.90313641 |
| 114 | metallo-sulfur cluster assembly (GO:0031163) | 2.90219156 |
| 115 | iron-sulfur cluster assembly (GO:0016226) | 2.90219156 |
| 116 | positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051437) | 2.90057961 |
| 117 | protein targeting to ER (GO:0045047) | 2.89506330 |
| 118 | GDP-mannose metabolic process (GO:0019673) | 2.89107758 |
| 119 | cotranslational protein targeting to membrane (GO:0006613) | 2.88832291 |
| 120 | positive regulation of action potential (GO:0045760) | 2.88602306 |
| 121 | cysteine metabolic process (GO:0006534) | 2.88427233 |
| 122 | pyrimidine deoxyribonucleotide metabolic process (GO:0009219) | 2.88048113 |
| 123 | negative regulation of mRNA splicing, via spliceosome (GO:0048025) | 2.86862156 |
| 124 | negative regulation of ligase activity (GO:0051352) | 2.86666263 |
| 125 | negative regulation of ubiquitin-protein transferase activity (GO:0051444) | 2.86666263 |
| 126 | acetyl-CoA metabolic process (GO:0006084) | 2.86476715 |
| 127 | rRNA methylation (GO:0031167) | 2.85789934 |
| 128 | amyloid precursor protein catabolic process (GO:0042987) | 2.85429270 |
| 129 | nuclear-transcribed mRNA catabolic process, nonsense-mediated decay (GO:0000184) | 2.85101482 |
| 130 | pyrimidine-containing compound transmembrane transport (GO:0072531) | 2.85060793 |
| 131 | cellular component biogenesis (GO:0044085) | 2.84130618 |
| 132 | electron transport chain (GO:0022900) | 2.84122195 |
| 133 | anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0 | 2.82901605 |
| 134 | sphingosine metabolic process (GO:0006670) | 2.82114253 |
| 135 | rRNA transcription (GO:0009303) | 2.81423572 |
| 136 | eye photoreceptor cell differentiation (GO:0001754) | 2.80719052 |
| 137 | photoreceptor cell differentiation (GO:0046530) | 2.80719052 |
| 138 | deoxyribonucleotide catabolic process (GO:0009264) | 2.80067595 |
| 139 | deoxyribose phosphate catabolic process (GO:0046386) | 2.79653176 |
| 140 | leukocyte migration involved in inflammatory response (GO:0002523) | 2.78935807 |
| 141 | protein localization to endoplasmic reticulum (GO:0070972) | 2.78811141 |
| 142 | DNA topological change (GO:0006265) | 2.77306890 |
| 143 | acyl-CoA metabolic process (GO:0006637) | 2.77212997 |
| 144 | thioester metabolic process (GO:0035383) | 2.77212997 |
| 145 | regulation of lipoprotein metabolic process (GO:0050746) | 2.76663635 |
| 146 | proline biosynthetic process (GO:0006561) | 2.76209606 |
| 147 | establishment of protein localization to endoplasmic reticulum (GO:0072599) | 2.75599892 |
| 148 | pentose-phosphate shunt (GO:0006098) | 2.75550714 |
| 149 | positive regulation of oligodendrocyte differentiation (GO:0048714) | 2.75457709 |
| 150 | regulation of cellular amino acid metabolic process (GO:0006521) | 2.75360377 |
| 151 | glycosylceramide metabolic process (GO:0006677) | 2.75351207 |
| 152 | translation (GO:0006412) | 2.75319924 |
| 153 | glutathione derivative biosynthetic process (GO:1901687) | 2.75075082 |
| 154 | glutathione derivative metabolic process (GO:1901685) | 2.75075082 |
| 155 | rRNA processing (GO:0006364) | 2.73146624 |
| 156 | protein targeting to mitochondrion (GO:0006626) | 2.72556160 |
| 157 | valine metabolic process (GO:0006573) | 2.72447262 |
| 158 | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:00 | 2.72366249 |
| 159 | negative regulation of cell size (GO:0045792) | 2.72329042 |
| 160 | NADPH regeneration (GO:0006740) | 2.71853441 |
| 161 | negative regulation of acute inflammatory response (GO:0002674) | 2.71027444 |
| 162 | spliceosomal snRNP assembly (GO:0000387) | 2.70220208 |
| 163 | signal transduction involved in mitotic DNA integrity checkpoint (GO:1902403) | 2.68719900 |
| 164 | signal transduction involved in mitotic DNA damage checkpoint (GO:1902402) | 2.68719900 |
| 165 | signal transduction involved in mitotic cell cycle checkpoint (GO:0072413) | 2.68719900 |
| 166 | intracellular signal transduction involved in G1 DNA damage checkpoint (GO:1902400) | 2.68476464 |
| 167 | signal transduction involved in mitotic G1 DNA damage checkpoint (GO:0072431) | 2.68476464 |
| 168 | signal transduction involved in DNA integrity checkpoint (GO:0072401) | 2.66397225 |
| 169 | signal transduction involved in DNA damage checkpoint (GO:0072422) | 2.66397225 |
| 170 | glycine metabolic process (GO:0006544) | 2.65770239 |
| 171 | tRNA aminoacylation for protein translation (GO:0006418) | 2.65537420 |
| 172 | negative regulation of mRNA processing (GO:0050686) | 2.65283215 |
| 173 | regulation of helicase activity (GO:0051095) | 2.63796258 |
| 174 | positive regulation of ubiquitin-protein transferase activity (GO:0051443) | 2.63765829 |
| 175 | viral life cycle (GO:0019058) | 2.63535556 |
| 176 | rRNA metabolic process (GO:0016072) | 2.61047506 |
| 177 | peptidyl-arginine omega-N-methylation (GO:0035247) | 2.59445428 |
| 178 | folic acid metabolic process (GO:0046655) | 2.58770014 |
| 179 | negative regulation of RNA splicing (GO:0033119) | 2.58136487 |
| 180 | signal transduction involved in cell cycle checkpoint (GO:0072395) | 2.57575847 |
| 181 | positive regulation of ligase activity (GO:0051351) | 2.57427191 |
| 182 | tRNA aminoacylation (GO:0043039) | 2.55718043 |
| 183 | amino acid activation (GO:0043038) | 2.55718043 |
| 184 | telomere maintenance via recombination (GO:0000722) | 2.54012958 |
| 185 | histone H2A acetylation (GO:0043968) | 2.53026529 |
| 186 | mitochondrial DNA metabolic process (GO:0032042) | 2.53016130 |
| 187 | regulation of translational fidelity (GO:0006450) | 2.52400460 |
| 188 | regulation of translation in response to stress (GO:0043555) | 2.52377076 |
| 189 | folic acid-containing compound biosynthetic process (GO:0009396) | 2.51710858 |
| 190 | telomere maintenance via telomere lengthening (GO:0010833) | 2.50887213 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 6.46995141 |
| 2 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 5.06093964 |
| 3 | E2F7_22180533_ChIP-Seq_HELA_Human | 4.38552279 |
| 4 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 3.95738962 |
| 5 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 3.87233409 |
| 6 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 3.61017565 |
| 7 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 3.49534570 |
| 8 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 3.42412795 |
| 9 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 3.23521776 |
| 10 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 3.17480498 |
| 11 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 3.16476545 |
| 12 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 3.15359857 |
| 13 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 2.95566543 |
| 14 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 2.69035476 |
| 15 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 2.52485946 |
| 16 | * HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 2.47192682 |
| 17 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 2.26265136 |
| 18 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 2.17672996 |
| 19 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 2.10550389 |
| 20 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 2.10368459 |
| 21 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 2.03815186 |
| 22 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 2.00670121 |
| 23 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.95620107 |
| 24 | * MYC_22102868_ChIP-Seq_BL_Human | 1.94473592 |
| 25 | GATA1_22025678_ChIP-Seq_K562_Human | 1.91769271 |
| 26 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 1.90786293 |
| 27 | ZFX_18555785_ChIP-Seq_MESCs_Mouse | 1.87885218 |
| 28 | VDR_23849224_ChIP-Seq_CD4+_Human | 1.75117101 |
| 29 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.74008950 |
| 30 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.69785070 |
| 31 | TTF2_22483619_ChIP-Seq_HELA_Human | 1.67336494 |
| 32 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.65055384 |
| 33 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.63945933 |
| 34 | STAT1_20625510_ChIP-Seq_HELA_Human | 1.57598305 |
| 35 | XRN2_22483619_ChIP-Seq_HELA_Human | 1.57230870 |
| 36 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 1.56637567 |
| 37 | * FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.56294455 |
| 38 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 1.56252127 |
| 39 | GATA1_19941826_ChIP-Seq_K562_Human | 1.56243403 |
| 40 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 1.56148565 |
| 41 | * E2F1_18555785_ChIP-Seq_MESCs_Mouse | 1.54928200 |
| 42 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 1.54135177 |
| 43 | IRF1_19129219_ChIP-ChIP_H3396_Human | 1.54063553 |
| 44 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.50616942 |
| 45 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.47848871 |
| 46 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.46761421 |
| 47 | DCP1A_22483619_ChIP-Seq_HELA_Human | 1.46326945 |
| 48 | MYC_19030024_ChIP-ChIP_MESCs_Mouse | 1.40942167 |
| 49 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.40847555 |
| 50 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.39722662 |
| 51 | CREB1_23762244_ChIP-Seq_HIPPOCAMPUS_Rat | 1.39003289 |
| 52 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.37348075 |
| 53 | * CTCF_20526341_ChIP-Seq_ESCs_Human | 1.35580091 |
| 54 | EOMES_21245162_ChIP-Seq_HESCs_Human | 1.35139058 |
| 55 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.34475783 |
| 56 | YY1_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.33833189 |
| 57 | GABP_19822575_ChIP-Seq_HepG2_Human | 1.33711335 |
| 58 | * TFEB_21752829_ChIP-Seq_HELA_Human | 1.33190120 |
| 59 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.31985585 |
| 60 | * YY1_22570637_ChIP-Seq_MALME-3M_Human | 1.29766796 |
| 61 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.29255504 |
| 62 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.29217996 |
| 63 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 1.27829017 |
| 64 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.26935777 |
| 65 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 1.26074652 |
| 66 | SOX17_20123909_ChIP-Seq_XEN_Mouse | 1.25285104 |
| 67 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.25066672 |
| 68 | * KLF1_20508144_ChIP-Seq_FETAL-LIVER-ERYTHROID_Mouse | 1.24938088 |
| 69 | NANOG_20526341_ChIP-Seq_ESCs_Human | 1.23503856 |
| 70 | NANOG_18555785_ChIP-Seq_MESCs_Mouse | 1.21695751 |
| 71 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.21154198 |
| 72 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 1.21126084 |
| 73 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.18659608 |
| 74 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.18542403 |
| 75 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 1.17656756 |
| 76 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.16992459 |
| 77 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 1.15880098 |
| 78 | PRDM5_23873026_ChIP-Seq_MEFs_Mouse | 1.11019897 |
| 79 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 1.10624588 |
| 80 | CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 1.09996192 |
| 81 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.08940188 |
| 82 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.08439506 |
| 83 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.08344501 |
| 84 | * GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.07816475 |
| 85 | PADI4_21655091_ChIP-ChIP_MCF-7_Human | 1.07500037 |
| 86 | E2F4_21247883_ChIP-Seq_LYMPHOBLASTOID_Human | 1.07315140 |
| 87 | CREB1_20920259_ChIP-Seq_GC1-SPG_Mouse | 1.06886081 |
| 88 | AR_21909140_ChIP-Seq_LNCAP_Human | 1.04702426 |
| 89 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 1.03839571 |
| 90 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.01558375 |
| 91 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 0.99837193 |
| 92 | SPI1_23547873_ChIP-Seq_NB4_Human | 0.99626181 |
| 93 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 0.99612486 |
| 94 | UTX_26944678_Chip-Seq_JUKART_Human | 0.98766867 |
| 95 | TBX5_21415370_ChIP-Seq_HL-1_Mouse | 0.98749439 |
| 96 | CNOT3_19339689_ChIP-ChIP_MESCs_Mouse | 0.98432952 |
| 97 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 0.97143608 |
| 98 | * BCOR_27268052_Chip-Seq_Bcells_Human | 0.96704981 |
| 99 | MYBL2_22936984_ChIP-ChIP_MESCs_Mouse | 0.95409753 |
| 100 | MAF_26560356_Chip-Seq_TH1_Human | 0.95116884 |
| 101 | SOX2_16153702_ChIP-ChIP_HESCs_Human | 0.95026153 |
| 102 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 0.94941496 |
| 103 | * OCT4_20526341_ChIP-Seq_ESCs_Human | 0.94461737 |
| 104 | GATA6_21074721_ChIP-Seq_CACO-2_Mouse | 0.93779678 |
| 105 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 0.93764650 |
| 106 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 0.93104977 |
| 107 | MYCN_18555785_ChIP-Seq_MESCs_Mouse | 0.92866999 |
| 108 | TAF15_26573619_Chip-Seq_HEK293_Human | 0.92415369 |
| 109 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 0.90590591 |
| 110 | MAF_26560356_Chip-Seq_TH2_Human | 0.90274356 |
| 111 | * CREM_20920259_ChIP-Seq_GC1-SPG_Mouse | 0.90007702 |
| 112 | CRX_20693478_ChIP-Seq_ADULT_RETINA_Mouse | 0.89705826 |
| 113 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 0.89618139 |
| 114 | KDM5A_27292631_Chip-Seq_BREAST_Human | 0.88957402 |
| 115 | SOX2_18692474_ChIP-Seq_MEFs_Mouse | 0.88672182 |
| 116 | P63_20808887_ChIP-Seq_KERATINOCYTES_Human | 0.87169604 |
| 117 | * HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 0.87006779 |
| 118 | KLF4_18555785_ChIP-Seq_MESCs_Mouse | 0.86643309 |
| 119 | MYC_18940864_ChIP-ChIP_HL60_Human | 0.86420770 |
| 120 | * TET1_21451524_ChIP-Seq_MESCs_Mouse | 0.86296529 |
| 121 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 0.86180635 |
| 122 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 0.85654258 |
| 123 | * CTCF_18555785_ChIP-Seq_MESCs_Mouse | 0.85475157 |
| 124 | ZFP42_18358816_ChIP-ChIP_MESCs_Mouse | 0.84622327 |
| 125 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 0.83694663 |
| 126 | KLF4_18264089_ChIP-ChIP_MESCs_Mouse | 0.83439360 |
| 127 | KLF2_18264089_ChIP-ChIP_MESCs_Mouse | 0.83439360 |
| 128 | VDR_22108803_ChIP-Seq_LS180_Human | 0.83149952 |
| 129 | FOXP1_21924763_ChIP-Seq_HESCs_Human | 0.80286676 |
| 130 | GATA1_26923725_Chip-Seq_HPCs_Mouse | 0.80032386 |
| 131 | KLF4_19030024_ChIP-ChIP_MESCs_Mouse | 0.77931694 |
| 132 | * SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 0.77645338 |
| 133 | POU5F1_18555785_ChIP-Seq_MESCs_Mouse | 0.76478607 |
| 134 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 0.76262983 |
| 135 | ELK1_19687146_ChIP-ChIP_HELA_Human | 0.76003066 |
| 136 | EOMES_20176728_ChIP-ChIP_TSCs_Mouse | 0.75954451 |
| 137 | TCFCP2L1_18555785_ChIP-Seq_MESCs_Mouse | 0.74875257 |
| 138 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 0.74689098 |
| 139 | * ASH2L_23239880_ChIP-Seq_MESCs_Mouse | 0.74491351 |
| 140 | SA1_27219007_Chip-Seq_Bcells_Human | 0.73307116 |
| 141 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.73256349 |
| 142 | GRHL2_25758223_ChIP-Seq_PLACENTA_Mouse | 0.73120408 |
| 143 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 0.72106639 |
| 144 | NCOR_22424771_ChIP-Seq_293T_Human | 0.71953889 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003806_abnormal_nucleotide_metabolis | 5.21996878 |
| 2 | MP0004147_increased_porphyrin_level | 5.11196403 |
| 3 | MP0000920_abnormal_myelination | 5.05366222 |
| 4 | MP0003656_abnormal_erythrocyte_physiolo | 5.03296419 |
| 5 | MP0005451_abnormal_body_composition | 4.07861914 |
| 6 | MP0008058_abnormal_DNA_repair | 3.66524687 |
| 7 | MP0003111_abnormal_nucleus_morphology | 3.63128853 |
| 8 | MP0003693_abnormal_embryo_hatching | 3.53601508 |
| 9 | MP0003950_abnormal_plasma_membrane | 3.13414365 |
| 10 | MP0001529_abnormal_vocalization | 2.97890306 |
| 11 | MP0003329_amyloid_beta_deposits | 2.95266810 |
| 12 | MP0003077_abnormal_cell_cycle | 2.77764907 |
| 13 | MP0001905_abnormal_dopamine_level | 2.58492538 |
| 14 | MP0003786_premature_aging | 2.57033037 |
| 15 | MP0010094_abnormal_chromosome_stability | 2.52864052 |
| 16 | MP0003763_abnormal_thymus_physiology | 2.41996816 |
| 17 | MP0002139_abnormal_hepatobiliary_system | 2.31636011 |
| 18 | MP0009840_abnormal_foam_cell | 2.19786869 |
| 19 | MP0003690_abnormal_glial_cell | 2.14031384 |
| 20 | MP0003718_maternal_effect | 2.11228147 |
| 21 | MP0004270_analgesia | 2.04565256 |
| 22 | MP0009697_abnormal_copulation | 2.01396575 |
| 23 | MP0002396_abnormal_hematopoietic_system | 1.99692126 |
| 24 | MP0004142_abnormal_muscle_tone | 1.99262982 |
| 25 | MP0008007_abnormal_cellular_replicative | 1.93166468 |
| 26 | MP0008260_abnormal_autophagy | 1.88230692 |
| 27 | MP0005360_urolithiasis | 1.82476795 |
| 28 | MP0000604_amyloidosis | 1.78385547 |
| 29 | MP0004381_abnormal_hair_follicle | 1.76575560 |
| 30 | MP0005083_abnormal_biliary_tract | 1.74788562 |
| 31 | MP0001545_abnormal_hematopoietic_system | 1.74505934 |
| 32 | MP0005397_hematopoietic_system_phenotyp | 1.74505934 |
| 33 | MP0005410_abnormal_fertilization | 1.73766121 |
| 34 | MP0008875_abnormal_xenobiotic_pharmacok | 1.72457894 |
| 35 | MP0002229_neurodegeneration | 1.72256269 |
| 36 | MP0001485_abnormal_pinna_reflex | 1.72171590 |
| 37 | MP0000350_abnormal_cell_proliferation | 1.70664544 |
| 38 | MP0003634_abnormal_glial_cell | 1.69732276 |
| 39 | MP0003136_yellow_coat_color | 1.67523171 |
| 40 | MP0003632_abnormal_nervous_system | 1.66589737 |
| 41 | MP0004885_abnormal_endolymph | 1.64961906 |
| 42 | MP0000313_abnormal_cell_death | 1.58131087 |
| 43 | MP0008057_abnormal_DNA_replication | 1.57529311 |
| 44 | MP0001873_stomach_inflammation | 1.52675694 |
| 45 | MP0000703_abnormal_thymus_morphology | 1.52401726 |
| 46 | MP0003186_abnormal_redox_activity | 1.50302523 |
| 47 | MP0006036_abnormal_mitochondrial_physio | 1.50239428 |
| 48 | MP0001764_abnormal_homeostasis | 1.48517889 |
| 49 | MP0005408_hypopigmentation | 1.46401911 |
| 50 | MP0002398_abnormal_bone_marrow | 1.45708072 |
| 51 | MP0001853_heart_inflammation | 1.45110934 |
| 52 | MP0004043_abnormal_pH_regulation | 1.44394027 |
| 53 | MP0008995_early_reproductive_senescence | 1.43094650 |
| 54 | MP0001661_extended_life_span | 1.42650479 |
| 55 | MP0003880_abnormal_central_pattern | 1.42520403 |
| 56 | MP0005332_abnormal_amino_acid | 1.42366948 |
| 57 | MP0002272_abnormal_nervous_system | 1.40166075 |
| 58 | MP0000490_abnormal_crypts_of | 1.38839889 |
| 59 | MP0004742_abnormal_vestibular_system | 1.38781826 |
| 60 | MP0002722_abnormal_immune_system | 1.36827251 |
| 61 | MP0000689_abnormal_spleen_morphology | 1.35354787 |
| 62 | MP0003195_calcinosis | 1.33377285 |
| 63 | MP0002019_abnormal_tumor_incidence | 1.33054703 |
| 64 | MP0002080_prenatal_lethality | 1.31914270 |
| 65 | MP0004185_abnormal_adipocyte_glucose | 1.31845083 |
| 66 | MP0005085_abnormal_gallbladder_physiolo | 1.30604683 |
| 67 | MP0000747_muscle_weakness | 1.27961992 |
| 68 | MP0006082_CNS_inflammation | 1.27436623 |
| 69 | MP0009278_abnormal_bone_marrow | 1.27007893 |
| 70 | MP0001697_abnormal_embryo_size | 1.19934693 |
| 71 | MP0008932_abnormal_embryonic_tissue | 1.17668989 |
| 72 | MP0009672_abnormal_birth_weight | 1.12614310 |
| 73 | MP0005501_abnormal_skin_physiology | 1.12161758 |
| 74 | MP0000358_abnormal_cell_content/ | 1.11435727 |
| 75 | MP0002429_abnormal_blood_cell | 1.10578055 |
| 76 | MP0001672_abnormal_embryogenesis/_devel | 1.10519825 |
| 77 | MP0005380_embryogenesis_phenotype | 1.10519825 |
| 78 | MP0001348_abnormal_lacrimal_gland | 1.08040732 |
| 79 | MP0000751_myopathy | 1.05959258 |
| 80 | MP0004808_abnormal_hematopoietic_stem | 1.05359329 |
| 81 | MP0005636_abnormal_mineral_homeostasis | 1.01753900 |
| 82 | MP0004782_abnormal_surfactant_physiolog | 1.01393961 |
| 83 | MP0005330_cardiomyopathy | 1.01370898 |
| 84 | MP0004233_abnormal_muscle_weight | 1.00041720 |
| 85 | MP0002653_abnormal_ependyma_morphology | 0.99755557 |
| 86 | MP0000465_gastrointestinal_hemorrhage | 0.99353110 |
| 87 | MP0000678_abnormal_parathyroid_gland | 0.98979276 |
| 88 | MP0001346_abnormal_lacrimal_gland | 0.98387982 |
| 89 | MP0001881_abnormal_mammary_gland | 0.97694523 |
| 90 | MP0008961_abnormal_basal_metabolism | 0.97350719 |
| 91 | MP0003984_embryonic_growth_retardation | 0.96497750 |
| 92 | MP0002163_abnormal_gland_morphology | 0.96434927 |
| 93 | MP0005409_darkened_coat_color | 0.95739124 |
| 94 | MP0002822_catalepsy | 0.94467149 |
| 95 | MP0000716_abnormal_immune_system | 0.92442605 |
| 96 | MP0002088_abnormal_embryonic_growth/wei | 0.91182937 |
| 97 | MP0009333_abnormal_splenocyte_physiolog | 0.91084559 |
| 98 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.91031912 |
| 99 | MP0001486_abnormal_startle_reflex | 0.90774276 |
| 100 | MP0005365_abnormal_bile_salt | 0.90232458 |
| 101 | MP0000462_abnormal_digestive_system | 0.89864684 |
| 102 | MP0003011_delayed_dark_adaptation | 0.89493429 |
| 103 | MP0005464_abnormal_platelet_physiology | 0.89465367 |
| 104 | MP0000598_abnormal_liver_morphology | 0.88646041 |
| 105 | MP0001851_eye_inflammation | 0.88574719 |
| 106 | MP0005319_abnormal_enzyme/_coenzyme | 0.88546262 |
| 107 | MP0002118_abnormal_lipid_homeostasis | 0.83753314 |
| 108 | MP0009765_abnormal_xenobiotic_induced | 0.83632087 |
| 109 | MP0008789_abnormal_olfactory_epithelium | 0.82988153 |
| 110 | MP0005621_abnormal_cell_physiology | 0.82977248 |
| 111 | MP0003937_abnormal_limbs/digits/tail_de | 0.82868161 |
| 112 | MP0005384_cellular_phenotype | 0.82489527 |
| 113 | MP0002420_abnormal_adaptive_immunity | 0.81305861 |
| 114 | MP0002734_abnormal_mechanical_nocicepti | 0.80675064 |
| 115 | MP0000613_abnormal_salivary_gland | 0.80417312 |
| 116 | MP0001819_abnormal_immune_cell | 0.80330843 |
| 117 | MP0002086_abnormal_extraembryonic_tissu | 0.79818730 |
| 118 | MP0001727_abnormal_embryo_implantation | 0.79794291 |
| 119 | MP0002102_abnormal_ear_morphology | 0.79427702 |
| 120 | MP0001986_abnormal_taste_sensitivity | 0.79212549 |
| 121 | MP0000955_abnormal_spinal_cord | 0.78916681 |
| 122 | MP0003938_abnormal_ear_development | 0.77312301 |
| 123 | MP0002405_respiratory_system_inflammati | 0.76938274 |
| 124 | MP0002269_muscular_atrophy | 0.76654120 |
| 125 | MP0003631_nervous_system_phenotype | 0.76505993 |
| 126 | MP0009785_altered_susceptibility_to | 0.76066480 |
| 127 | MP0003436_decreased_susceptibility_to | 0.75606103 |
| 128 | MP0001849_ear_inflammation | 0.74958817 |
| 129 | MP0003221_abnormal_cardiomyocyte_apopto | 0.74262807 |
| 130 | MP0002085_abnormal_embryonic_tissue | 0.74201408 |
| 131 | MP0002752_abnormal_somatic_nervous | 0.74177822 |
| 132 | MP0000749_muscle_degeneration | 0.72420389 |
| 133 | MP0001730_embryonic_growth_arrest | 0.71067001 |
| 134 | MP0002066_abnormal_motor_capabilities/c | 0.70994111 |
| 135 | MP0000383_abnormal_hair_follicle | 0.70837850 |
| 136 | MP0005379_endocrine/exocrine_gland_phen | 0.70763092 |
| 137 | MP0005075_abnormal_melanosome_morpholog | 0.70181321 |
| 138 | MP0002084_abnormal_developmental_patter | 0.68725163 |
| 139 | MP0005000_abnormal_immune_tolerance | 0.68600020 |
| 140 | MP0002138_abnormal_hepatobiliary_system | 0.67980783 |
| 141 | MP0000778_abnormal_nervous_system | 0.67276761 |
| 142 | MP0002064_seizures | 0.66656022 |
| 143 | MP0005058_abnormal_lysosome_morphology | 0.66194245 |
| 144 | MP0000750_abnormal_muscle_regeneration | 0.65538981 |
| 145 | MP0005171_absent_coat_pigmentation | 0.65126612 |
| 146 | MP0001800_abnormal_humoral_immune | 0.64142838 |
| 147 | MP0001666_abnormal_nutrient_absorption | 0.63733191 |
| 148 | MP0002882_abnormal_neuron_morphology | 0.63503941 |
| 149 | MP0010678_abnormal_skin_adnexa | 0.63405936 |
| 150 | MP0001963_abnormal_hearing_physiology | 0.63165061 |
| 151 | MP0006035_abnormal_mitochondrial_morpho | 0.61202895 |
| 152 | MP0001243_abnormal_dermal_layer | 0.60769797 |
| 153 | MP0009046_muscle_twitch | 0.60414870 |
| 154 | MP0005195_abnormal_posterior_eye | 0.60189674 |
| 155 | MP0000579_abnormal_nail_morphology | 0.59618966 |
| 156 | MP0000685_abnormal_immune_system | 0.58962188 |
| 157 | MP0000467_abnormal_esophagus_morphology | 0.57552058 |
| 158 | MP0001970_abnormal_pain_threshold | 0.57005843 |
| 159 | MP0004924_abnormal_behavior | 0.56093314 |
| 160 | MP0005386_behavior/neurological_phenoty | 0.56093314 |
| 161 | MP0000372_irregular_coat_pigmentation | 0.55620577 |
| 162 | MP0000609_abnormal_liver_physiology | 0.54775816 |
| 163 | MP0005395_other_phenotype | 0.53520508 |
| 164 | MP0005266_abnormal_metabolism | 0.53383452 |
| 165 | MP0002132_abnormal_respiratory_system | 0.51593905 |
| 166 | MP0003191_abnormal_cellular_cholesterol | 0.51442503 |
| 167 | MP0009643_abnormal_urine_homeostasis | 0.51279351 |
| 168 | MP0004957_abnormal_blastocyst_morpholog | 0.50516654 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Atrophy/Degeneration involving the corticospinal tracts (HP:0007372) | 5.77897295 |
| 2 | Degeneration of the lateral corticospinal tracts (HP:0002314) | 5.77897295 |
| 3 | Abnormality of the heme biosynthetic pathway (HP:0010472) | 5.22794774 |
| 4 | Abnormality of glycolysis (HP:0004366) | 5.18864300 |
| 5 | Increased serum pyruvate (HP:0003542) | 5.18864300 |
| 6 | Neurofibrillary tangles (HP:0002185) | 4.99998982 |
| 7 | Microvesicular hepatic steatosis (HP:0001414) | 4.98589433 |
| 8 | Parakeratosis (HP:0001036) | 4.85679889 |
| 9 | Cerebral hypomyelination (HP:0006808) | 4.82648436 |
| 10 | Sensory axonal neuropathy (HP:0003390) | 4.77776864 |
| 11 | Abnormality of the corticospinal tract (HP:0002492) | 4.32011424 |
| 12 | Exercise-induced myalgia (HP:0003738) | 4.23873393 |
| 13 | Exercise-induced muscle cramps (HP:0003710) | 3.86153758 |
| 14 | Congenital nonbullous ichthyosiform erythroderma (HP:0007479) | 3.77800882 |
| 15 | Cerebral inclusion bodies (HP:0100314) | 3.54920649 |
| 16 | Spastic paraparesis (HP:0002313) | 3.53039886 |
| 17 | Peripheral hypomyelination (HP:0007182) | 3.51033619 |
| 18 | Muscle stiffness (HP:0003552) | 3.35254202 |
| 19 | Aplastic anemia (HP:0001915) | 3.31513269 |
| 20 | Acanthocytosis (HP:0001927) | 3.27139499 |
| 21 | Calf muscle hypertrophy (HP:0008981) | 3.26487141 |
| 22 | Reduced antithrombin III activity (HP:0001976) | 3.17016209 |
| 23 | Cerebral hemorrhage (HP:0001342) | 3.16797210 |
| 24 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 3.15857581 |
| 25 | Paralysis (HP:0003470) | 3.15302268 |
| 26 | 3-Methylglutaconic aciduria (HP:0003535) | 3.15193188 |
| 27 | Leukodystrophy (HP:0002415) | 3.12549307 |
| 28 | Muscle hypertrophy of the lower extremities (HP:0008968) | 3.11765284 |
| 29 | Poikilocytosis (HP:0004447) | 3.11217581 |
| 30 | Cholecystitis (HP:0001082) | 3.06771857 |
| 31 | Abnormal gallbladder physiology (HP:0012438) | 3.06771857 |
| 32 | Acute necrotizing encephalopathy (HP:0006965) | 3.02729298 |
| 33 | Hepatocellular necrosis (HP:0001404) | 3.02637592 |
| 34 | Ragged-red muscle fibers (HP:0003200) | 2.96341361 |
| 35 | Posterior subcapsular cataract (HP:0007787) | 2.95523270 |
| 36 | Congenital ichthyosiform erythroderma (HP:0007431) | 2.90805971 |
| 37 | Acute encephalopathy (HP:0006846) | 2.85089441 |
| 38 | Rough bone trabeculation (HP:0100670) | 2.83422942 |
| 39 | Ileus (HP:0002595) | 2.83306334 |
| 40 | Progressive external ophthalmoplegia (HP:0000590) | 2.82303303 |
| 41 | Mitochondrial inheritance (HP:0001427) | 2.80407301 |
| 42 | Spastic gait (HP:0002064) | 2.78362265 |
| 43 | Renal Fanconi syndrome (HP:0001994) | 2.76254769 |
| 44 | CNS hypomyelination (HP:0003429) | 2.74623432 |
| 45 | Onion bulb formation (HP:0003383) | 2.73528204 |
| 46 | Intrahepatic cholestasis (HP:0001406) | 2.71942714 |
| 47 | Hypoplastic pelvis (HP:0008839) | 2.67449056 |
| 48 | Abnormal gallbladder morphology (HP:0012437) | 2.66603127 |
| 49 | Brushfield spots (HP:0001088) | 2.65731786 |
| 50 | Premature ovarian failure (HP:0008209) | 2.64402419 |
| 51 | Delusions (HP:0000746) | 2.61949322 |
| 52 | Multiple enchondromatosis (HP:0005701) | 2.57514017 |
| 53 | Type I transferrin isoform profile (HP:0003642) | 2.55092062 |
| 54 | Abnormal mitochondria in muscle tissue (HP:0008316) | 2.54895578 |
| 55 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 2.54695501 |
| 56 | Abnormal auditory evoked potentials (HP:0006958) | 2.53856073 |
| 57 | Abnormality of the left ventricular outflow tract (HP:0011103) | 2.52892446 |
| 58 | Subaortic stenosis (HP:0001682) | 2.52892446 |
| 59 | Progressive muscle weakness (HP:0003323) | 2.51745320 |
| 60 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 2.51401324 |
| 61 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 2.51401324 |
| 62 | Hepatic necrosis (HP:0002605) | 2.50294117 |
| 63 | Hypoglycemic seizures (HP:0002173) | 2.48912333 |
| 64 | Cholelithiasis (HP:0001081) | 2.48576685 |
| 65 | Increased hepatocellular lipid droplets (HP:0006565) | 2.42207077 |
| 66 | Abnormality of reticulocytes (HP:0004312) | 2.42088247 |
| 67 | Diaphragmatic weakness (HP:0009113) | 2.40349714 |
| 68 | Increased CSF lactate (HP:0002490) | 2.39261970 |
| 69 | Supranuclear gaze palsy (HP:0000605) | 2.38908874 |
| 70 | Postnatal microcephaly (HP:0005484) | 2.38305809 |
| 71 | Abnormality of the umbilical cord (HP:0010881) | 2.37948404 |
| 72 | Paraparesis (HP:0002385) | 2.35971851 |
| 73 | Pancytopenia (HP:0001876) | 2.34563777 |
| 74 | Hepatosplenomegaly (HP:0001433) | 2.34468673 |
| 75 | Hypoglycemic coma (HP:0001325) | 2.34315228 |
| 76 | Neuroendocrine neoplasm (HP:0100634) | 2.31984993 |
| 77 | Petechiae (HP:0000967) | 2.30226732 |
| 78 | Secondary amenorrhea (HP:0000869) | 2.30063206 |
| 79 | Pheochromocytoma (HP:0002666) | 2.29470243 |
| 80 | Abnormal protein glycosylation (HP:0012346) | 2.28994827 |
| 81 | Abnormal glycosylation (HP:0012345) | 2.28994827 |
| 82 | Abnormal isoelectric focusing of serum transferrin (HP:0003160) | 2.28994827 |
| 83 | Abnormal protein N-linked glycosylation (HP:0012347) | 2.28994827 |
| 84 | Autoamputation (HP:0001218) | 2.28137101 |
| 85 | Partial agenesis of the corpus callosum (HP:0001338) | 2.28007179 |
| 86 | Hyperglycinuria (HP:0003108) | 2.27481157 |
| 87 | Cerebral edema (HP:0002181) | 2.24318832 |
| 88 | Lipid accumulation in hepatocytes (HP:0006561) | 2.23925316 |
| 89 | Erythroderma (HP:0001019) | 2.23127375 |
| 90 | Hypoplasia of the thymus (HP:0000778) | 2.22403388 |
| 91 | Myopathic facies (HP:0002058) | 2.21859524 |
| 92 | Progressive macrocephaly (HP:0004481) | 2.18971656 |
| 93 | Rhabdomyolysis (HP:0003201) | 2.18651466 |
| 94 | Poor suck (HP:0002033) | 2.18458173 |
| 95 | Abnormal number of erythroid precursors (HP:0012131) | 2.18455958 |
| 96 | Akinesia (HP:0002304) | 2.16527002 |
| 97 | Abnormality of cells of the erythroid lineage (HP:0012130) | 2.16034200 |
| 98 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 2.15845420 |
| 99 | Oral leukoplakia (HP:0002745) | 2.15644849 |
| 100 | Seborrheic dermatitis (HP:0001051) | 2.15640389 |
| 101 | Slow saccadic eye movements (HP:0000514) | 2.14875749 |
| 102 | Pallor (HP:0000980) | 2.13853924 |
| 103 | Hyperbilirubinemia (HP:0002904) | 2.12947967 |
| 104 | Decreased activity of cytochrome C oxidase in muscle tissue (HP:0003688) | 2.12291565 |
| 105 | Hyperglycinemia (HP:0002154) | 2.12119144 |
| 106 | Increased muscle lipid content (HP:0009058) | 2.11852837 |
| 107 | Renal cortical cysts (HP:0000803) | 2.11197553 |
| 108 | Reticulocytosis (HP:0001923) | 2.11174310 |
| 109 | Deep venous thrombosis (HP:0002625) | 2.10430616 |
| 110 | CNS demyelination (HP:0007305) | 2.10397474 |
| 111 | Trismus (HP:0000211) | 2.10360678 |
| 112 | Premature skin wrinkling (HP:0100678) | 2.10093935 |
| 113 | Abnormality of fatty-acid metabolism (HP:0004359) | 2.09926706 |
| 114 | Hyperlipoproteinemia (HP:0010980) | 2.09114124 |
| 115 | Intention tremor (HP:0002080) | 2.05496339 |
| 116 | Distal lower limb muscle weakness (HP:0009053) | 2.04383125 |
| 117 | Respiratory failure (HP:0002878) | 2.03595550 |
| 118 | Reticulocytopenia (HP:0001896) | 2.03204718 |
| 119 | Exercise intolerance (HP:0003546) | 2.02827459 |
| 120 | Aplasia/Hypoplasia of the thymus (HP:0010515) | 2.01713948 |
| 121 | Increased serum lactate (HP:0002151) | 2.01404165 |
| 122 | Macrocytic anemia (HP:0001972) | 1.99170898 |
| 123 | Cerebral palsy (HP:0100021) | 1.97481935 |
| 124 | Entropion (HP:0000621) | 1.97464384 |
| 125 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 1.96113167 |
| 126 | Dicarboxylic aciduria (HP:0003215) | 1.96113167 |
| 127 | Abnormality of glycine metabolism (HP:0010895) | 1.95728760 |
| 128 | Abnormality of serine family amino acid metabolism (HP:0010894) | 1.95728760 |
| 129 | Hypobetalipoproteinemia (HP:0003563) | 1.95286511 |
| 130 | Abnormality of serum amino acid levels (HP:0003112) | 1.95246862 |
| 131 | Asymmetric septal hypertrophy (HP:0001670) | 1.95087518 |
| 132 | Confusion (HP:0001289) | 1.94531601 |
| 133 | Abnormal trabecular bone morphology (HP:0100671) | 1.93366299 |
| 134 | Dysmetria (HP:0001310) | 1.93291651 |
| 135 | Subcapsular cataract (HP:0000523) | 1.92895938 |
| 136 | Methylmalonic acidemia (HP:0002912) | 1.91606080 |
| 137 | Absent septum pellucidum (HP:0001331) | 1.91574895 |
| 138 | Acute hepatic failure (HP:0006554) | 1.91465504 |
| 139 | Muscle abnormality related to mitochondrial dysfunction (HP:0003800) | 1.89959164 |
| 140 | Abnormal cartilage morphology (HP:0002763) | 1.89608434 |
| 141 | Thickened helices (HP:0000391) | 1.88908294 |
| 142 | Neck muscle weakness (HP:0000467) | 1.88376658 |
| 143 | IgM deficiency (HP:0002850) | 1.88028124 |
| 144 | Increased intramyocellular lipid droplets (HP:0012240) | 1.87798125 |
| 145 | Exertional dyspnea (HP:0002875) | 1.86840282 |
| 146 | Xanthomatosis (HP:0000991) | 1.86653460 |
| 147 | Dry hair (HP:0011359) | 1.85994709 |
| 148 | Adrenal hypoplasia (HP:0000835) | 1.84923173 |
| 149 | Abnormal hemoglobin (HP:0011902) | 1.84771209 |
| 150 | Testicular atrophy (HP:0000029) | 1.84535074 |
| 151 | Hypertensive crisis (HP:0100735) | 1.84145611 |
| 152 | Abnormality of the fetal cardiovascular system (HP:0010948) | 1.83850582 |
| 153 | Abnormal umbilical cord blood vessels (HP:0011403) | 1.83850582 |
| 154 | Single umbilical artery (HP:0001195) | 1.83850582 |
| 155 | Breast hypoplasia (HP:0003187) | 1.82937854 |
| 156 | Termporal pattern (HP:0011008) | 1.81603023 |
| 157 | Insidious onset (HP:0003587) | 1.81603023 |
| 158 | Spastic tetraparesis (HP:0001285) | 1.80755326 |
| 159 | Death in infancy (HP:0001522) | 1.80021452 |
| 160 | Barrel-shaped chest (HP:0001552) | 1.78048814 |
| 161 | Anteriorly placed anus (HP:0001545) | 1.77864732 |
| 162 | Birth length less than 3rd percentile (HP:0003561) | 1.77345761 |
| 163 | Morphological abnormality of the pyramidal tract (HP:0002062) | 1.76732716 |
| 164 | Stridor (HP:0010307) | 1.76092148 |
| 165 | Abnormality of methionine metabolism (HP:0010901) | 1.75562834 |
| 166 | Abnormality of the gallbladder (HP:0005264) | 1.74998773 |
| 167 | Lethargy (HP:0001254) | 1.74698662 |
| 168 | Segmental peripheral demyelination/remyelination (HP:0003481) | 1.74226554 |
| 169 | Prolonged neonatal jaundice (HP:0006579) | 1.73210884 |
| 170 | Lactic acidosis (HP:0003128) | 1.73001500 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | STK39 | 6.26173968 |
| 2 | OXSR1 | 4.55029665 |
| 3 | VRK2 | 4.03797736 |
| 4 | CDK19 | 3.74892804 |
| 5 | SMG1 | 3.23749715 |
| 6 | PBK | 3.09405508 |
| 7 | SCYL2 | 3.06379032 |
| 8 | EPHB1 | 2.75794548 |
| 9 | WNK4 | 2.72899204 |
| 10 | SRPK1 | 2.57402782 |
| 11 | BCR | 2.46538667 |
| 12 | MET | 2.31517203 |
| 13 | LIMK1 | 2.19468615 |
| 14 | CDC7 | 2.15000286 |
| 15 | TESK2 | 2.13224136 |
| 16 | CSNK1G3 | 2.13217791 |
| 17 | ERN1 | 2.12793630 |
| 18 | BUB1 | 2.12422570 |
| 19 | CDK8 | 1.95294839 |
| 20 | PKN1 | 1.88321766 |
| 21 | MAPKAPK5 | 1.85354438 |
| 22 | TLK1 | 1.85179432 |
| 23 | ICK | 1.83464026 |
| 24 | TRIM28 | 1.70138309 |
| 25 | WNK1 | 1.69435733 |
| 26 | MST4 | 1.67946836 |
| 27 | ARAF | 1.66678328 |
| 28 | CSNK1A1L | 1.65290135 |
| 29 | NME2 | 1.63877760 |
| 30 | CSNK1G1 | 1.61506725 |
| 31 | FGR | 1.59853439 |
| 32 | NUAK1 | 1.59358519 |
| 33 | ZAK | 1.59105374 |
| 34 | EIF2AK1 | 1.53899843 |
| 35 | STK16 | 1.52572839 |
| 36 | TESK1 | 1.45626102 |
| 37 | DYRK2 | 1.45344422 |
| 38 | GRK6 | 1.43921449 |
| 39 | PLK4 | 1.43520684 |
| 40 | CSNK1G2 | 1.42479483 |
| 41 | PRPF4B | 1.38601949 |
| 42 | CCNB1 | 1.33671151 |
| 43 | UHMK1 | 1.31065346 |
| 44 | TSSK6 | 1.22285440 |
| 45 | NTRK1 | 1.20613309 |
| 46 | TNIK | 1.18187986 |
| 47 | CLK1 | 1.14990940 |
| 48 | ERBB4 | 1.13030499 |
| 49 | ROCK2 | 1.12240868 |
| 50 | NME1 | 1.12219755 |
| 51 | EIF2AK2 | 1.10178678 |
| 52 | TAF1 | 1.08066156 |
| 53 | DAPK1 | 1.07068500 |
| 54 | RPS6KA5 | 1.05955745 |
| 55 | STK10 | 1.05083005 |
| 56 | SIK3 | 1.04838576 |
| 57 | CDK4 | 1.04398931 |
| 58 | PNCK | 1.02693820 |
| 59 | AURKA | 1.02681099 |
| 60 | BCKDK | 1.01374413 |
| 61 | ABL2 | 1.00598449 |
| 62 | RPS6KB2 | 1.00144748 |
| 63 | NEK6 | 0.99667567 |
| 64 | TBK1 | 0.96108335 |
| 65 | TAOK2 | 0.95996636 |
| 66 | PLK1 | 0.93694977 |
| 67 | CDK14 | 0.90962009 |
| 68 | PAK6 | 0.90093813 |
| 69 | CDK9 | 0.89530967 |
| 70 | PLK3 | 0.87678018 |
| 71 | VRK1 | 0.87526575 |
| 72 | CAMK2G | 0.87455662 |
| 73 | PASK | 0.86151332 |
| 74 | CAMK2D | 0.84985328 |
| 75 | ATR | 0.83771467 |
| 76 | PRKCQ | 0.80009547 |
| 77 | CAMK2B | 0.79998252 |
| 78 | PIM1 | 0.79647562 |
| 79 | CDK11A | 0.79204142 |
| 80 | DYRK3 | 0.78987671 |
| 81 | MAP3K10 | 0.78857588 |
| 82 | CDK15 | 0.78622369 |
| 83 | NEK1 | 0.77707658 |
| 84 | BMPR1B | 0.76720168 |
| 85 | BRAF | 0.74472708 |
| 86 | MAPK11 | 0.74283154 |
| 87 | LRRK2 | 0.73087389 |
| 88 | MAP2K3 | 0.71366820 |
| 89 | AURKB | 0.70754854 |
| 90 | IKBKE | 0.70356090 |
| 91 | PAK1 | 0.70095655 |
| 92 | MAP3K8 | 0.70072810 |
| 93 | PIK3CG | 0.69126125 |
| 94 | CDK18 | 0.67865153 |
| 95 | CHEK1 | 0.64992719 |
| 96 | RPS6KA4 | 0.64398913 |
| 97 | PDK2 | 0.64209166 |
| 98 | KSR2 | 0.63850019 |
| 99 | WEE1 | 0.63461965 |
| 100 | TYK2 | 0.62623089 |
| 101 | STK4 | 0.61777327 |
| 102 | MAP3K14 | 0.59430029 |
| 103 | PAK4 | 0.58860842 |
| 104 | MOS | 0.58340139 |
| 105 | TRPM7 | 0.58162065 |
| 106 | TAOK1 | 0.57473937 |
| 107 | MAP2K2 | 0.57152918 |
| 108 | IRAK3 | 0.56698781 |
| 109 | RAF1 | 0.55922277 |
| 110 | MAP3K3 | 0.53188923 |
| 111 | MAP3K11 | 0.53089917 |
| 112 | PRKCI | 0.52751088 |
| 113 | PDPK1 | 0.52613160 |
| 114 | BRSK1 | 0.52176155 |
| 115 | MAP3K13 | 0.51686908 |
| 116 | MUSK | 0.51633292 |
| 117 | MARK2 | 0.50726088 |
| 118 | PINK1 | 0.49768232 |
| 119 | ITK | 0.49176698 |
| 120 | CSNK2A1 | 0.47966024 |
| 121 | CDK6 | 0.47635516 |
| 122 | CSF1R | 0.47104260 |
| 123 | DMPK | 0.46190847 |
| 124 | CSNK1D | 0.46004642 |
| 125 | PRKD1 | 0.45942493 |
| 126 | FES | 0.45904399 |
| 127 | MAP4K1 | 0.42940963 |
| 128 | PIM2 | 0.42819385 |
| 129 | AKT2 | 0.39156049 |
| 130 | CDK5 | 0.37860265 |
| 131 | TRIB3 | 0.37166364 |
| 132 | MAPKAPK2 | 0.36817173 |
| 133 | ZAP70 | 0.36465836 |
| 134 | KDR | 0.36188785 |
| 135 | CDK2 | 0.36110752 |
| 136 | TEC | 0.35862131 |
| 137 | BTK | 0.35443033 |
| 138 | CSNK1A1 | 0.34885780 |
| 139 | ALK | 0.34814825 |
| 140 | CHEK2 | 0.34083133 |
| 141 | EIF2AK3 | 0.33638167 |
| 142 | CAMK2A | 0.33356253 |
| 143 | LCK | 0.32423347 |
| 144 | MKNK1 | 0.30321713 |
| 145 | ABL1 | 0.30013039 |
| 146 | OBSCN | 0.28857398 |
| 147 | NEK2 | 0.28694282 |
| 148 | FGFR2 | 0.28298382 |
| 149 | PRKACB | 0.27645365 |
| 150 | SGK494 | 0.25498137 |
| 151 | SGK223 | 0.25498137 |
| 152 | TAOK3 | 0.25399261 |
| 153 | CDK7 | 0.24680502 |
| 154 | CSNK2A2 | 0.23288395 |
| 155 | IKBKB | 0.22145868 |
| 156 | PAK3 | 0.21325347 |
| 157 | TTK | 0.21079672 |
| 158 | FYN | 0.20717791 |
| 159 | MELK | 0.18887017 |
| 160 | LATS2 | 0.17787167 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 5.18259033 |
| 2 | Fatty acid elongation_Homo sapiens_hsa00062 | 4.00945759 |
| 3 | Steroid biosynthesis_Homo sapiens_hsa00100 | 3.90259729 |
| 4 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 3.53199139 |
| 5 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 3.16139934 |
| 6 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.81583793 |
| 7 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 2.63543103 |
| 8 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 2.61400953 |
| 9 | Protein export_Homo sapiens_hsa03060 | 2.58058341 |
| 10 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 2.55306486 |
| 11 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.43298153 |
| 12 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 2.36260553 |
| 13 | Ether lipid metabolism_Homo sapiens_hsa00565 | 2.29571208 |
| 14 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 2.28779097 |
| 15 | Parkinsons disease_Homo sapiens_hsa05012 | 2.14182700 |
| 16 | RNA polymerase_Homo sapiens_hsa03020 | 2.13115112 |
| 17 | Proteasome_Homo sapiens_hsa03050 | 2.11072414 |
| 18 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 2.10571532 |
| 19 | Folate biosynthesis_Homo sapiens_hsa00790 | 2.05821825 |
| 20 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.79433423 |
| 21 | Histidine metabolism_Homo sapiens_hsa00340 | 1.74018687 |
| 22 | Sulfur relay system_Homo sapiens_hsa04122 | 1.73779476 |
| 23 | Ribosome_Homo sapiens_hsa03010 | 1.71136431 |
| 24 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.70513665 |
| 25 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 1.57736126 |
| 26 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.56495839 |
| 27 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 1.52334146 |
| 28 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 1.52101362 |
| 29 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.50631555 |
| 30 | Alzheimers disease_Homo sapiens_hsa05010 | 1.48864800 |
| 31 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.46834859 |
| 32 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 1.39608353 |
| 33 | Glutathione metabolism_Homo sapiens_hsa00480 | 1.37037000 |
| 34 | Huntingtons disease_Homo sapiens_hsa05016 | 1.36912198 |
| 35 | Basal transcription factors_Homo sapiens_hsa03022 | 1.32114685 |
| 36 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 1.30038037 |
| 37 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 1.27418057 |
| 38 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.27073881 |
| 39 | Peroxisome_Homo sapiens_hsa04146 | 1.22485348 |
| 40 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.18044982 |
| 41 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.13240036 |
| 42 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.12597882 |
| 43 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.08868622 |
| 44 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 1.04222217 |
| 45 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.98659152 |
| 46 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.95543918 |
| 47 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.94210922 |
| 48 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 0.94000155 |
| 49 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.93649949 |
| 50 | Metabolic pathways_Homo sapiens_hsa01100 | 0.92483357 |
| 51 | Galactose metabolism_Homo sapiens_hsa00052 | 0.89415340 |
| 52 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.88337723 |
| 53 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.87155914 |
| 54 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.86115086 |
| 55 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.83300280 |
| 56 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.79207162 |
| 57 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.77182984 |
| 58 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.76310741 |
| 59 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.76273314 |
| 60 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.75293184 |
| 61 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.73649353 |
| 62 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.68514247 |
| 63 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.68232107 |
| 64 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.68143077 |
| 65 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.67920078 |
| 66 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.67572528 |
| 67 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 0.66169192 |
| 68 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.65277545 |
| 69 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.65196079 |
| 70 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.64519223 |
| 71 | Retinol metabolism_Homo sapiens_hsa00830 | 0.63996375 |
| 72 | Non-homologous end-joining_Homo sapiens_hsa03450 | 0.62461314 |
| 73 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.62386331 |
| 74 | Nucleotide excision repair_Homo sapiens_hsa03420 | 0.61953479 |
| 75 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.60846348 |
| 76 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.60799427 |
| 77 | DNA replication_Homo sapiens_hsa03030 | 0.60544323 |
| 78 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.58886803 |
| 79 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.58618009 |
| 80 | Homologous recombination_Homo sapiens_hsa03440 | 0.58291648 |
| 81 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.57751487 |
| 82 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.56953627 |
| 83 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.55889766 |
| 84 | Spliceosome_Homo sapiens_hsa03040 | 0.55744108 |
| 85 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.54383635 |
| 86 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.50629120 |
| 87 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.50508554 |
| 88 | Lysine degradation_Homo sapiens_hsa00310 | 0.50252739 |
| 89 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.48800928 |
| 90 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.48778025 |
| 91 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.45964578 |
| 92 | Thyroid cancer_Homo sapiens_hsa05216 | 0.44835861 |
| 93 | Carbon metabolism_Homo sapiens_hsa01200 | 0.42809701 |
| 94 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.42234835 |
| 95 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.41507383 |
| 96 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.41066254 |
| 97 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.39906375 |
| 98 | Purine metabolism_Homo sapiens_hsa00230 | 0.39670160 |
| 99 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.39137648 |
| 100 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.38650741 |
| 101 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.37410013 |
| 102 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.36790272 |
| 103 | Malaria_Homo sapiens_hsa05144 | 0.36679728 |
| 104 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.35271094 |
| 105 | Apoptosis_Homo sapiens_hsa04210 | 0.34869808 |
| 106 | Mismatch repair_Homo sapiens_hsa03430 | 0.33936403 |
| 107 | Cell cycle_Homo sapiens_hsa04110 | 0.32895081 |
| 108 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.32058155 |
| 109 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.31760859 |
| 110 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.29671490 |
| 111 | Shigellosis_Homo sapiens_hsa05131 | 0.28708592 |
| 112 | ABC transporters_Homo sapiens_hsa02010 | 0.28511571 |
| 113 | Axon guidance_Homo sapiens_hsa04360 | 0.26755428 |
| 114 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.26752096 |
| 115 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 0.26499330 |
| 116 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.26099810 |
| 117 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.24499614 |
| 118 | Tight junction_Homo sapiens_hsa04530 | 0.24304723 |
| 119 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.23947633 |
| 120 | Endocytosis_Homo sapiens_hsa04144 | 0.22931372 |
| 121 | Alcoholism_Homo sapiens_hsa05034 | 0.21710143 |
| 122 | Base excision repair_Homo sapiens_hsa03410 | 0.20673665 |
| 123 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.19770052 |
| 124 | RNA transport_Homo sapiens_hsa03013 | 0.18692375 |
| 125 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.18312587 |
| 126 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.16479414 |
| 127 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.15420538 |
| 128 | RNA degradation_Homo sapiens_hsa03018 | 0.13960382 |
| 129 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.12506581 |

